These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 9394341

  • 1. Tacrolimus treatment for steroid- and cyclosporin-resistant minimal-change nephrotic syndrome.
    Schweda F, Liebl R, Riegger GA, Krämer BK.
    Nephrol Dial Transplant; 1997 Nov; 12(11):2433-5. PubMed ID: 9394341
    [No Abstract] [Full Text] [Related]

  • 2. Use of tacrolimus in steroid- and cyclophosphamide-resistant minimal change nephrotic syndrome.
    Tang S, Tang AW, Tam MK, Ho YW.
    Am J Kidney Dis; 2003 Nov; 42(5):E13-5. PubMed ID: 14582073
    [Abstract] [Full Text] [Related]

  • 3. Randomized, Controlled Trial of Tacrolimus and Prednisolone Monotherapy for Adults with De Novo Minimal Change Disease: A Multicenter, Randomized, Controlled Trial.
    Medjeral-Thomas NR, Lawrence C, Condon M, Sood B, Warwicker P, Brown H, Pattison J, Bhandari S, Barratt J, Turner N, Cook HT, Levy JB, Lightstone L, Pusey C, Galliford J, Cairns TD, Griffith M.
    Clin J Am Soc Nephrol; 2020 Feb 07; 15(2):209-218. PubMed ID: 31953303
    [Abstract] [Full Text] [Related]

  • 4. Tacrolimus improves proteinuria remission in adults with cyclosporine A-resistant or -dependent minimal change disease.
    Xu D, Gao X, Bian R, Mei C, Xu C.
    Nephrology (Carlton); 2017 Mar 07; 22(3):251-256. PubMed ID: 28035723
    [Abstract] [Full Text] [Related]

  • 5. [Minimal Change Glomerulonephritis].
    Stracke S, Helmchen U, Aymanns C, Kadlec N, Lindemann B, Hüttner S, Keller F.
    Internist (Berl); 2003 Sep 07; 44(9):1090-7. PubMed ID: 14566462
    [Abstract] [Full Text] [Related]

  • 6. [Treatment of steroid-dependent minimal change-nephrotic syndrome with mycophenolate mofetil].
    Noroña B, Valentín M, Gutiérrez E, Praga M.
    Nefrologia; 2004 Sep 07; 24(1):79-82. PubMed ID: 15083963
    [Abstract] [Full Text] [Related]

  • 7. Chronic nephrotoxicity limits successful use of Tacrolimus in the management of adult steroid-dependent minimal change disease.
    Ramachandran R, Kumar D A P, Nada R, Jha V, Gupta KL, Kohli HS.
    Nephrology (Carlton); 2015 May 07; 20(5):384-5. PubMed ID: 25872662
    [No Abstract] [Full Text] [Related]

  • 8. A case of early-stage diabetic nephropathy complicated by minimal change nephrotic syndrome treated with cyclosporin A.
    Matsuda M, Hayashi Y, Shikata K, Makino H, Shikata Y, Sugimoto H, Akiyama K, Kushiro M, Ota Z.
    Nephron; 1997 May 07; 75(4):490-1. PubMed ID: 9127341
    [No Abstract] [Full Text] [Related]

  • 9. The treatment of minimal change disease in adults.
    Hogan J, Radhakrishnan J.
    J Am Soc Nephrol; 2013 Apr 07; 24(5):702-11. PubMed ID: 23431071
    [Abstract] [Full Text] [Related]

  • 10. Treatment with cyclosporin of patients with idiopathic nephrotic syndrome.
    Meyrier A.
    Springer Semin Immunopathol; 1987 Apr 07; 9(4):441-50. PubMed ID: 3324370
    [No Abstract] [Full Text] [Related]

  • 11. Minimal change (steroid sensitive) nephrotic syndrome in children: new aspects on pathogenesis and treatment.
    Oh J, Kemper MJ.
    Minerva Pediatr; 2012 Apr 07; 64(2):197-204. PubMed ID: 22495193
    [Abstract] [Full Text] [Related]

  • 12. Transition of severe diffuse mesangial hypercellularity to minimal change disease in a child with steroid-resistant nephrotic syndrome.
    Fujinaga S, Watanabe T, Endo A, Hirano D, Ohtomo Y, Shimizu T, Kaneko K.
    Clin Nephrol; 2011 Dec 07; 76(6):504-6. PubMed ID: 22105456
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of the Efficacy and Safety of Tacrolimus and Low-Dose Corticosteroid with High-Dose Corticosteroid for Minimal Change Nephrotic Syndrome in Adults.
    Chin HJ, Chae DW, Kim YC, An WS, Ihm C, Jin DC, Kim SG, Kim YL, Kim YS, Kim YG, Koo HS, Lee JE, Lee KW, Oh J, Park JH, Jiang H, Lee H, Lee SK.
    J Am Soc Nephrol; 2021 Jan 07; 32(1):199-210. PubMed ID: 33168602
    [Abstract] [Full Text] [Related]

  • 14. Chronic cyclosporine-induced nephrotoxicity in children with steroid-resistant nephrotic syndrome.
    Fujinaga S, Shimizu T.
    Pediatr Nephrol; 2013 Oct 07; 28(10):2065-6. PubMed ID: 23780471
    [No Abstract] [Full Text] [Related]

  • 15. [Therapy of the nephrotic syndrome in children].
    Linneweh F.
    Minerva Med; 1973 Oct 27; 64(76):4007-9. PubMed ID: 4764071
    [No Abstract] [Full Text] [Related]

  • 16. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
    Li X, Li H, Ye H, Li Q, He X, Zhang X, Chen Y, Han F, He Q, Wang H, Chen J.
    Am J Kidney Dis; 2009 Jul 27; 54(1):51-8. PubMed ID: 19406543
    [Abstract] [Full Text] [Related]

  • 17. Successful treatment of steroid-resistant minimal change disease with mycophenolate mofetil.
    Mogyorósi A, Lippman HR, Feldman GM.
    Am J Nephrol; 2002 Jul 27; 22(5-6):569-72. PubMed ID: 12381961
    [Abstract] [Full Text] [Related]

  • 18. Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome : workshop recommendations.
    Cattran DC, Alexopoulos E, Heering P, Hoyer PF, Johnston A, Meyrier A, Ponticelli C, Saito T, Choukroun G, Nachman P, Praga M, Yoshikawa N.
    Kidney Int; 2007 Dec 27; 72(12):1429-47. PubMed ID: 17898700
    [Abstract] [Full Text] [Related]

  • 19. Induction of remission following a single dose of rituximab alone in a patient with minimal change nephrotic syndrome.
    Amemiya N, Takei T, Kojima C, Nokiba H, Itabashi M, Nitta K.
    Clin Exp Nephrol; 2011 Dec 27; 15(6):933-6. PubMed ID: 21823044
    [Abstract] [Full Text] [Related]

  • 20. Combined immunosuppressive therapy in steroid-resistant, chronic glomerular diseases of childhood.
    Campbell RA, Jacinto EY.
    J Lancet; 1967 May 27; 87(5):149-56 passim. PubMed ID: 6043891
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.